{"generation": 90, "stage": "population", "candidate_idx": 0, "weights": {"risk_aversion": 0.45999954000046006, "herd_behavior": 0.28999971000029, "profit_driven": 0.24999975000025002}, "mean_reward": -0.1445726744661349, "std_reward": 0.0, "mean_abs_error": 0.1445726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.04, "abs_error": 0.1445726744661349, "reward": -0.1445726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding to align closer to the benchmark weight or manage risk exposure is likely, leading to a negative normalized log change.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 1, "weights": {"risk_aversion": 0.43999956000044005, "herd_behavior": 0.27999972000028006, "profit_driven": 0.27999972000028006}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock presents a mix of attractive fundamentals and elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk, though the elevated volatility could temper the magnitude of any adjustment.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 2, "weights": {"risk_aversion": 0.5119994880005121, "herd_behavior": 0.24999975000025002, "profit_driven": 0.237999762000238}, "mean_reward": -0.16457267446613488, "std_reward": 0.0, "mean_abs_error": 0.16457267446613488, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.06, "abs_error": 0.16457267446613488, "reward": -0.16457267446613488, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to align closer to the benchmark while managing risk exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.06}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 3, "weights": {"risk_aversion": 0.5088423873511602, "herd_behavior": 0.2227346451524601, "profit_driven": 0.26842196749636954}, "mean_reward": -0.1445726744661349, "std_reward": 0.0, "mean_abs_error": 0.1445726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.04, "abs_error": 0.1445726744661349, "reward": -0.1445726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high beta (1.44) and significant market volatility (prev quarter stock_vol_q_prev = 0.1276), the stock presents elevated systematic risk. The fund's current holding is substantial relative to its AUM and the stock's S&P 500 weight, suggesting potential for rebalancing towards the benchmark. Considering the high beta and the fund's medium turnover constraint, a modest reduction in holding might be expected to align closer with the lower-beta benchmark weight while managing risk exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 4, "weights": {"risk_aversion": 0.47999952000048, "herd_behavior": 0.26999973000027006, "profit_driven": 0.24999975000025002}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 5, "weights": {"risk_aversion": 0.47999952000048, "herd_behavior": 0.26999973000027006, "profit_driven": 0.24999975000025002}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 6, "weights": {"risk_aversion": 0.47999952000048, "herd_behavior": 0.26999973000027006, "profit_driven": 0.24999975000025002}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 7, "weights": {"risk_aversion": 0.48999951000049, "herd_behavior": 0.25999974000026005, "profit_driven": 0.24999975000025002}, "mean_reward": -0.1445726744661349, "std_reward": 0.0, "mean_abs_error": 0.1445726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.04, "abs_error": 0.1445726744661349, "reward": -0.1445726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is relatively small compared to AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. Considering the high beta and the fund's low turnover constraint, a modest increase in holding might be expected to align with the positive fundamentals while managing risk exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 8, "weights": {"risk_aversion": 0.5288423873511655, "herd_behavior": 0.24273464515246254, "profit_driven": 0.22842196749637184}, "mean_reward": -0.1445726744661349, "std_reward": 0.0, "mean_abs_error": 0.1445726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.04, "abs_error": 0.1445726744661349, "reward": -0.1445726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be overweight compared to benchmark. Considering the high beta and the fund's medium turnover constraint, a reduction in holding might be expected to manage risk exposure, though the positive fundamentals could support maintaining or slightly increasing the position.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 9, "weights": {"risk_aversion": 0.5088423873511654, "herd_behavior": 0.26273464515246275, "profit_driven": 0.22842196749637186}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.4418), the stock appears fundamentally strong but with elevated systematic risk. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight is modest, suggesting the position may be a significant active allocation. Considering the high beta and the fund's medium turnover constraint, a modest increase in holding could be expected to align with the positive fundamentals while managing risk exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 10, "weights": {"risk_aversion": 0.501999498000502, "herd_behavior": 0.26999973000027006, "profit_driven": 0.22799977200022803}, "mean_reward": -0.1445726744661349, "std_reward": 0.0, "mean_abs_error": 0.1445726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.04, "abs_error": 0.1445726744661349, "reward": -0.1445726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.228) and growth (Gat=0.244), alongside a beta above 1 indicating higher systematic risk than the market, the stock appears fundamentally strong but with elevated volatility. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with benchmark exposure. However, the high beta and recent stock volatility may temper the magnitude of any increase, leading to a modest positive adjustment.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 90, "stage": "population", "candidate_idx": 11, "weights": {"risk_aversion": 0.4199996850001313, "herd_behavior": 0.27999979000008757, "profit_driven": 0.2999995250005313}, "mean_reward": -0.1245726744661349, "std_reward": 0.0, "mean_abs_error": 0.1245726744661349, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 694, "quarter": "NA", "permno": 20482, "date": "2017-04-01 00:00:00", "holding_t": 27641.646308, "ticker": "ABT", "company": "ABBOTT LABORATORIES", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0082565895035254, "x_herd_mean": 0.0069532062192367, "x_profit_mean": 0.2194993243101532, "overall_mean": 0.0782363733443051, "y_true": 0.1045726744661349, "pred": -0.02, "abs_error": 0.1245726744661349, "reward": -0.1245726744661349, "best_k": 1, "completion": "\n<think>Given the firm's high profitability (profit=0.2279) and growth (Gat=0.2444), alongside its above-market beta (1.442) indicating higher systematic risk, the stock appears attractive for growth but carries elevated volatility. The fund's current holding is substantial relative to AUM, and the stock's S&P 500 weight suggests it is a significant benchmark component. Considering the high beta and the fund's existing large position, a modest increase in holding might be expected to align with the benchmark while managing concentration risk.</think>\n<answer>\n{\"holding_log_delta\": -0.02}\n</answer>", "valid": true}]}
